ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS April 2026 Foundayo is the second oral GLP-1 drug approved for weight management The issue: GLP-1 weight-loss therapies are the most talked-about drug class ever Why this matters: In January 2026, Wegovy tablets became the first oral GLP-1 drug approved for weight loss
Small Molecular Metabolite Targets for Treatment of Rheumatoid Arthritis Previous research has shown that small molecular metabolites, like PGs, LTs, LXs, PAF, ROS, and NO, support to induce, maintain, or relieve inflammation in RA ( Table 2 )
Nutritional interventions, especially increased protein intake, may offer protective effects against muscle loss, though GLP-1 RAs therapies may inadvertently suppress protein-rich food consumption
Strong muscular contractions break down food particles and gradually release them into the small intestine at a controlled rate
Because your body is constantly using its antioxidant stores to fight environmental stress, you need to replenish them daily
Peter also covers key nutrition strategieslike protein intake, timing, and creatine supplementationand offers practical advice for everyone from beginners to seasoned lifters on building and maintaining muscle safely and sustainably
